Intel will license certain technology and patents from ZiiLABS, a wholly-owned subsidiary of Creative Technology, and acquire certain engineering resources and assets
The $50 million (£31.4 million) deal includes $20 million to Creative for the licensing of certain technologies to Intel relating to ZiiLABS' high performance GPU technology. The second part of the deal is $30 million for the transfer of certain engineering resources and assets. The UK subsidiary is a engaged in the development of various silicon solutions, including the ZMS chips for Creative.
“As the next generation advanced media processors beyond 28 nanometers become increasingly complex and expensive to develop we must find new models to work with our partners and customers to drive continued product innovation. With this announcement we gain increased flexibility with the ability to partner with multiple semiconductor companies on advanced design and process technologies, allowing us to mitigate risk while maintaining control over the long-term direction of our product portfolio. Moving forward, it will be more cost effective for Creative to outsource to third party contract chip-layout houses on future advanced chips for its products, while at the same time allowing Creative to focus on its core strength - the designing and marketing of more innovative and exciting products for our customers.” said Sim Wong Hoo, CEO of Creative Technology.
ZiiLABS (still wholly-owned by Creative) will continue to retain all ownership of its StemCell media processor technologies and patents, and continue to supply and support its ZMS series of chips to its customers. It will also continue to develop devices incorporating the ZiiLABS ZMS-20 and the ZMS-40 media processors.
“Creative will continue to retain ownership of its formidable patent portfolio in the field of 3D graphics and media processing. We will be engaging in discussions to further monetize this valuable collection of 100 plus patents,” added Sim Wong Hoo.
De ZMS-40 mediaprocessor, een van de producten uit het ZiiLABS-portfolio.